Relaxin-3-deficient mice showed slight alteration in anxiety-related behavior

Frontiers in Behavioral Neuroscience

Volumn , Issue AUGUST, 2011, Pages

  Watanabe, Yoshihisa ^a   Tsujimura, Atsushi ^a   Takao, Keizo ^b,c   Nishi, Kazunori ^d   Ito, Yasuaki ^d   Yasuhara, Yoshitaka ^d   Nakatomi, Yasuhito ^a   Yokoyama, Chihiro ^a   Fukui, Kenji ^a   Miyakawa, Tsuyoshi ^b,c   Tanaka, Masaki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c FUJITA HEALTH UNIVERSITY   (Japan)

^d TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

Anxiety; Elevated plus maze; Gene knockout; Mouse; Relaxin 3

Indexed keywords

RELAXIN 3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BODY WEIGHT; CONDITIONING; CONTROLLED STUDY; DEPRESSION; EMOTION; FEAR; FORCED SWIMMING TEST; GENE; GENOTYPE; GROWTH; HOT PLATE TEST; KNOCKOUT MOUSE; LIGHT DARK CYCLE; LOCOMOTION; MALE; MAZE TEST; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RELAXIN 3 GENE; ROTAROD TEST; SENSORY SYSTEM; SOCIAL INTERACTION; STARTLE REFLEX; WILD TYPE;

EID: 84855189628     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2011.00050     Document Type: Article

References (49)

1. Anseloni, V. Z., and Brandao, M. L. (1997). Ethopharmacological analysis of behaviour of rats using variations of the elevated plus-maze. Behav. Pharmacol. 8, 533-540.
2. Anseloni, V. Z., Motta, V., Lima, G., and Brandao, M. L. (1995). Behavioral and pharmacological validation of the elevated plus maze constructed with transparent walls. Braz. J. Med. Biol. Res. 28, 597-601.
3. Bathgate, R. A., Samuel, C. S., Burazin, T. C., Layfield, S., Claasz, A. A., Reytomas, I. G., Dawson, N. F., Zhao, C., Bond, C., Summers, R. J., Parry, L. J., Wade, J. D., and Tregear, G. W. (2002). Human relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene. Novel members of the relaxin peptide family. J. Biol. Chem. 277, 1148-1157.
4. Boels, K., and Schaller, H. C. (2003). Identification and characterisation of GPR100 as a novel human G-protein-coupled bradykinin receptor. Br. J. Pharmacol. 140, 932-938.
5. Bullesbach, E. E., Yang, S., and Schwabe, C. (1992). The receptor-binding site of human relaxin II. A dual prong-binding mechanism. J. Biol. Chem. 267, 22957-22960.
6. Burazin, T. C., Bathgate, R. A., Macris, M., Layfield, S., Gundlach, A. L., and Tregear, G. W. (2002). Restricted, but abundant, expression of the novel rat gene-3 (R3) relaxin in the dorsal tegmental region of brain. J. Neurochem. 82, 1553-1557.
7. Conti, L. H., Murry, J. D., Ruiz, M. A., and Printz, M. P. (2002). Effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in two rat strains. Psychopharmacology (Berl.) 161, 296-303.
8. Dirks, A., Groenink, L., Schipholt, M. I., van der Gugten, J., Hijzen, T. H., Geyer, M. A., and Olivier, B. (2002). Reduced startle reactivity and plasticity in transgenic mice overexpressing corticotropin-releasing hormone. Biol. Psychiatry 51, 583-590.
9. Geyer, M. A., McIlwain, K. L., and Paylor, R. (2002). Mouse genetic models for prepulse inhibition: an early review. Mol. Psychiatry 7, 1039-1053.
10. Hida, T., Takahashi, E., Shikata, K., Hirohashi, T., Sawai, T., Seiki, T., Tanaka, H., Kawai, T., Ito, O., Arai, T., Yokoi, A., Hirakawa, T., Ogura, H., Nagasu, T., Miyamoto, N., and Kuromitsu, J. (2006). Chronic intracerebroventricular administration of relaxin-3 increases body weight in rats. J. Recept. Signal Transduct. Res. 26, 147-158.
11. Hollopeter, G., Erickson, J. C., Seeley, R. J., Marsh, D. J., and Palmiter, R. D. (1998). Response of neuropeptide Y-deficient mice to feeding effectors. Regul. Pept. 75-76, 383-389.
12. James, R., Niall, H., Kwok, S., and Bryand-Greenwood, G. (1977). Primary structure of porcine relaxin: homology with insulin and related growth factors. Nature 267, 544-546.
13. Kizawa, H., Nishi, K., Ishibashi, Y., Harada, M., Asano, T., Ito, Y., Suzuki, N., Hinuma, S., Fujisawa, Y., Onda, H., Nishimura, O., and Fujino, M. (2003). Production of recombinant human relaxin 3 in AtT20 cells. Regul. Pept. 113, 79-84.
14. Koch, M., and Schnitzler, H. U. (1997). The acoustic startle response in rats-circuits mediating evocation, inhibition and potentiation. Behav. Brain Res. 89, 35-49.
15. Komada, M., Takao, K., and Miyakawa, T. (2008). Elevated plus maze for mice. J. Vis. Exp. 1088. Available at: http://www.jove.com/details.php?id=1088
16. Liu, C., Chen, J., Kuei, C., Sutton, S., Nepomuceno, D., Bonaventure, P., and Lovenberg, T. W. (2005a). Relaxin-3/ insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7. Mol. Pharmacol. 67, 231-240.
17. Liu, C., Kuei, C., Sutton, S., Chen, J., Bonaventure, P., Wu, J., Nepomuceno, D., Kamme, F., Tran, D. T., Zhu, J., Wilkinson, T., Bathgate, R., Eriste, E., Sillard, R., and Lovenberg, T. W. (2005b). INSL5 is a high affinity specific agonist for GPCR142 (GPR100). J. Biol. Chem. 280, 292-300.
18. Liu, C., Eriste, E., Sutton, S., Chen, J., Roland, B., Kuei, C., Farmer, N., Jornvall, H., Sillard, R., and Lovenberg, T. W. (2003). Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135. J. Biol. Chem. 278, 50754-50764.
19. Ma, S., Bonaventure, P., Ferraro, T., Shen, P. J., Burazin, T. C., Bathgate, R. A., Liu, C., Tregear, G. W., Sutton, S. W., and Gundlach, A. L. (2007). Relaxin-3 in GABA projection neurons of nucleus incertus suggests widespread influence on forebrain circuits via G-protein-coupled receptor-135 in the rat. Neuroscience 144, 165-190.
20. Ma, S., Olucha-Bordonau, F. E., Hossain, M. A., Lin, F., Kuei, C., Liu, C., Wade, J. D., Sutton, S. W., Nunez, A., and Gundlach, A. L. (2009). Modulation of hippocampal theta oscillations and spatial memory by relaxin-3 neurons of the nucleus incertus. Learn. Mem. 16, 730-742.
21. Ma, S., Shen, P. J., Burazin, T. C., Tregear, G. W., and Gundlach, A. L. (2006). Comparative localization of leucine-rich repeat-containing G-protein-coupled receptor-7 (RXFP1) mRNA and [33P]-relaxin binding sites in rat brain: restricted somatic co-expression a clue to relaxin action? Neuroscience 141, 329-344.
22. McGowan, B. M., Stanley, S. A., Smith, K. L., Minnion, J. S., Donovan, J., Thompson, E. L., Patterson, M., Connolly, M. M., Abbott, C. R., Small, C. J., Gardiner, J. V., Ghatei, M. A., and Bloom, S. R. (2006). Effects of acute and chronic relaxin-3 on food intake and energy expenditure in rats. Regul. Pept. 136, 72-77.
23. McGowan, B. M., Stanley, S. A., Smith, K. L., White, N. E., Connolly, M. M., Thompson, E. L., Gardiner, J. V., Murphy, K. G., Ghatei, M. A., and Bloom, S. R. (2005). Central relaxin-3 administration causes hyperphagia in male Wistar rats. Endocrinology 146, 3295-3300.
24. McGowan, B. M., Stanley, S. A., White, N. E., Spangeus, A., Patterson, M., Thompson, E. L., Smith, K. L., Donovan, J., Gardiner, J. V., Ghatei, M. A., and Bloom, S. R. (2007). Hypothalamic mapping of orexi-genic action and Fos-like immu-noreactivity following relaxin-3 administration in male Wistar rats. Am. J. Physiol. Endocrinol. Metab. 292, E913-E919.
25. Miyakawa, T., Yamada, M., Duttaroy, A., and Wess, J. (2001). Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J. Neurosci. 21, 5239-5250.
26. Parada-Turska, J., and Turski, W. A. (1990). Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks. Neuropharmacology 29, 1111-1116.
27. Reul, J. M., and Holsboer, F. (2002). Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr. Opin. Pharmacol. 2, 23-33.
28. Risbrough, V. B., Hauger, R. L., Roberts, A. L., Vale, W. W., and Geyer, M. A. (2004). Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior. J. Neurosci. 24, 6545-6552.
29. Rotzinger, S., Lovejoy, D. A., and Tan, L. A. (2010). Behavioral effects of neuro-peptides in rodent models of depression and anxiety. Peptides 31, 736-756.
30. Sherwood, O. D. (1994). "Relaxin," in The Physiology of Reproduction, eds E. Knobil and J. Neil (New York: Raven Press), 861-1009.
31. Smith, C. M., Lawrence, A. J., Sutton, S. W., and Gundlach, A. L. (2009). Behavioral phenotyping of mixed background (129S5:B6) relaxin-3 knockout mice. Ann. N. Y. Acad. Sci. 1160, 236-241.
32. Smith, C. M., Shen, P. J., Banerjee, A., Bonaventure, P., Ma, S., Bathgate, R. A., Sutton, S. W., and Gundlach, A. L. (2010). Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brain. J. Comp. Neurol. 518, 4016-4045.
33. Smith, G. W., Aubry, J. M., Dellu, F., Contarino, A., Bilezikjian, L. M., Gold, L. H., Chen, R., Marchuk, Y., Hauser, C., Bentley, C. A., Sawchenko, P. E., Koob, G. F., Vale, W., and Lee, K. F. (1998). Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroen-docrine development. Neuron 20, 1093-1102.
34. Stenzel-Poore, M. P., Heinrichs, S. C., Rivest, S., Koob, G. F., and Vale, W. W. (1994). Overproduction of cortico-tropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J. Neurosci. 14, 2579-2584.
35. Steru, L., Chermat, R., Thierry, B., and Simon, P. (1985). The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl.) 85, 367-370.
36. Sun, Y., Ahmed, S., and Smith, R. G. (2003). Deletion of ghrelin impairs neither growth nor appetite. Mol. Cell. Biol. 23, 7973-7981.
37. Sutherland, J. E., Burian, L. C., Covault, J., and Conti, L. H. (2010). The effect of restraint stress on prepulse inhibition and on corticotropin-releasing factor (CRF) and CRF receptor gene expression in Wistar-Kyoto and Brown Norway rats. Pharmacol. Biochem. Behav. 97, 227-238.
38. Sutton, S. W., Bonaventure, P., Kuei, C., Roland, B., Chen, J., Nepomuceno, D., Lovenberg, T. W., and Liu, C. (2004). Distribution of G-protein-coupled receptor (GPCR)135 binding sites and receptor mRNA in the rat brain suggests a role for relaxin-3 in neuroendocrine and sensory processing. Neuroendocrinology 80, 298-307.
39. Sutton, S. W., Shelton, J., Smith, C., Williams, J., Yun, S., Motley, T., Kuei, C., Bonaventure, P., Gundlach, A., Liu, C., and Lovenberg, T. (2009). Metabolic and neuroendocrine responses to RXFP3 modulation in the central nervous system. Ann. N. Y. Acad. Sci. 1160, 242-249.
40. Swanson, L. W., Sawchenko, P. E., Rivier, J., and Vale, W. W. (1983). Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohisto-chemical study. Neuroendocrinology 36, 165-186.
41. Takao, K., and Miyakawa, T. (2006). Light/ dark transition test for mice. J. Vis. Exp. 104. Available at: http://www.jove.com/details.php?id=104
42. Takao, K., Tanda, K., Nakamura, K., Kasahara, J., Nakao, K., Katsuki, M., Nakanishi, K., Yamasaki, N., Toyama, K., Adachi, M., Umeda, M., Araki, T., Fukunaga, K., Kondo, H., Sakagami, H., and Miyakawa, T. (2010). Comprehensive behavioral analysis of calcium/calmodulin-dependent protein kinase IV knockout mice. PLoS ONE 5, e9460.doi: 10.1371/journal. pone.0009460
43. Tamada, K., Tomonaga, S., Hatanaka, F., Nakai, N., Takao, K., Miyakawa, T., Nakatani, J., and Takumi, T. (2010). Decreased exploratory activity in a mouse model of 15q duplication syndrome; implications for disturbance of serotonin signaling. PLoS ONE 5, e15126. doi: 10.1371/journal. pone.0015126
44. Tanaka, M., Iijima, N., Miyamoto, Y., Fukusumi, S., Itoh, Y., Ozawa, H., and Ibata, Y. (2005). Neurons expressing relaxin 3/INSL 7 in the nucleus incertus respond to stress. Eur. J. Neurosci. 21, 1659-1670.
45. Timpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J. M., Stalla, G. K., Blanquet, V., Steckler, T., Holsboer, F., and Wurst, W. (1998). Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat. Genet. 19, 162-166.
46. Watanabe, Y., Miyamoto, Y., Matsuda, T., and Tanaka, M. (2011). Relaxin-3/INSL7 regulates the stress-response system in the rat hypothalamus. J. Mol. Neurosci. 43, 169-174.
47. Wilkinson, T. N., Speed, T. P., Tregear, G. W., and Bathgate, R. A. (2005). Evolution of the relaxin-like peptide family. BMC Evol. Biol. 5, 14. doi:10.1186/1471-2148-5-14
48. Yamasaki, N., Maekawa, M., Kobayashi, K., Kajii, Y., Maeda, J., Soma, M., Takao, K., Tanda, K., Ohira, K., Toyama, K., Kanzaki, K., Fukunaga, K., Sudo, Y., Ichinose, H., Ikeda, M., Iwata, N., Ozaki, N., Suzuki, H., Higuchi, M., Suhara, T., Yuasa, S., and Miyakawa, T. (2008). Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders. Mol Brain 1, 6.
49. Zhao, L., Roche, P. J., Gunnersen, J. M., Hammond, V. E., Tregear, G. W., Wintour, E. M., and Beck, F. (1999). Mice without a functional relaxin gene are unable to deliver milk to their pups. Endocrinology 140, 445-453.